Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

[Association between serum calcium levels and the risk of liver cirrhosis].

Yin LY, Yin J, Cui JF, Liu B, Chen F, Fan JH, Chen W.

Zhonghua Liu Xing Bing Xue Za Zhi. 2013 May;34(5):457-60. Chinese.

PMID:
24016434
2.

[Prospective study of the association between fasting glucose concentrations and liver cirrhosis risk].

Yin LY, Chen W, Cui JF, Liu B, Yin J, Fan JH, Chen F, Liu XF, Fu CJ, Dai XB.

Zhonghua Gan Zang Bing Za Zhi. 2012 May;20(5):381-5. doi: 10.3760/cma.j.issn.1007-3418.2012.05.016. Chinese.

PMID:
22971286
3.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

PMID:
9758109
4.

[Prospective study on the relation between serum vitamin D levels and liver cirrhosis risk].

Yu LL, Yin LY, Chen W, Fan JH, Cui JF, Yin J, Qiao YL, Dai XB.

Zhonghua Gan Zang Bing Za Zhi. 2013 Mar;21(3):202-6. Chinese.

PMID:
23967742
5.

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.

Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxì A, Ciccaglione A, Giuseppetti R, et al.

Ann Intern Med. 1992 Jan 15;116(2):97-102.

PMID:
1309286
6.

The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.

Zhang M, Wu R, Jiang J, Minuk GY, Niu J.

Alcohol. 2013 Nov;47(7):553-8. doi: 10.1016/j.alcohol.2013.07.003. Epub 2013 Sep 13.

PMID:
24041840
7.

Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.

Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S; Italian Association of the Study of the Liver Disease (AISF).

Am J Gastroenterol. 2008 Aug;103(8):1966-72. doi: 10.1111/j.1572-0241.2008.01912.x. Epub 2008 Jul 12.

PMID:
18637087
8.

Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan.

Tsai JF, Chang WY, Jeng JE, Ho MS, Wang LY, Hsieh MY, Chen SC, Chuang WL, Lin ZY, Tsai JH.

J Med Virol. 1993 Dec;41(4):296-300.

PMID:
7508973
9.
10.

Association of hepatitis C virus with liver cirrhosis and hepatocellular carcinoma compared with hepatitis B virus in Egyptian patients.

Darwish MA, Amer AF, El-Moeity AA, Darwish NM.

J Egypt Public Health Assoc. 1997;72(5-6):569-89.

PMID:
17214153
11.

Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.

Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.

Scand J Gastroenterol. 2008;43(7):849-56. doi: 10.1080/00365520801935459.

PMID:
18584524
12.

Habitual betel quid chewing as a risk factor for cirrhosis: a case-control study.

Tsai JF, Jeng JE, Chuang LY, Ho MS, Ko YC, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Ho C.

Medicine (Baltimore). 2003 Sep;82(5):365-72.

13.

Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C.

Coppola N, Gentile I, Pasquale G, Buonomo AR, Capoluongo N, D'Armiento M, Borgia G, Sagnelli E.

Ann Hepatol. 2013 Jan-2014 Feb;13(1):20-6.

14.

Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.

Peters M, Wellek S, Dienes HP, Junginger T, Meyer J, Meyer Zum Büschendfelde KH, Gerken G.

Z Gastroenterol. 1994 Mar;32(3):146-51.

PMID:
8197809
15.

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.

El-Serag HB, Richardson PA, Everhart JE.

Am J Gastroenterol. 2001 Aug;96(8):2462-7.

PMID:
11513191
16.

Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.

Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK.

J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. Epub 2007 Jun 7.

PMID:
17559381
17.

High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.

Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-Szalmas P.

J Hepatol. 2013 Sep;59(3):457-66. doi: 10.1016/j.jhep.2013.04.018. Epub 2013 Apr 29.

PMID:
23639483
19.

Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study.

Kwon OS, Jung YK, Bae KS, Kim JH, Kim SG, Kim YS, Lee JI, Lee JW, Kim YS.

Alcohol. 2012 Sep;46(6):537-41. doi: 10.1016/j.alcohol.2012.03.006. Epub 2012 May 7.

PMID:
22572059
20.

Occult hepatitis B virus infection in Chinese cryptogenic intrahepatic cholangiocarcinoma patient population.

Li Y, Wang H, Li D, Hu J, Wang H, Zhou D, Li Q, Jiang X, Zhou H, Hu H.

J Clin Gastroenterol. 2014 Nov-Dec;48(10):878-82. doi: 10.1097/MCG.0000000000000058.

PMID:
24356457

Supplemental Content

Support Center